These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8523154)

  • 21. Reactions to booster pneumococcal vaccination in patients with sickle cell disease.
    Rigau-Perez JG; Overturf GD; Chan LS; Weiss J; Powars D
    Pediatr Infect Dis; 1983; 2(3):199-202. PubMed ID: 6346278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute febrile systemic reaction to polyvalent pneumococcal vaccine.
    Gabor EP; Seeman M
    JAMA; 1979 Nov; 242(20):2208-9. PubMed ID: 40046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical inquiries. Should patients receive 23-valent pneumococcal vaccination more than once?
    Whiteside J; Grover M; Hitchcock K; Kim R
    J Fam Pract; 2006 Sep; 55(9):809-12. PubMed ID: 16948967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of pneumococcal pneumonia by immunization with pneumococcal polysaccharide vaccine (Pneumovax).
    Helms CM
    J Iowa Med Soc; 1978 Aug; 68(8):282-3. PubMed ID: 29072
    [No Abstract]   [Full Text] [Related]  

  • 25. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia.
    Törling J; Hedlund J; Konradsen HB; Ortqvist A
    Vaccine; 2003 Dec; 22(1):96-103. PubMed ID: 14604576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revaccination of high-risk adults with pneumococcal polysaccharide vaccine.
    Nichol KL
    JAMA; 1999 Jan; 281(3):280-1. PubMed ID: 9918486
    [No Abstract]   [Full Text] [Related]  

  • 27. Pneumococcal vaccine. Health and Public Policy Committee, American College of Physicians.
    Ann Intern Med; 1986 Jan; 104(1):118-20. PubMed ID: 3940479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of pneumococcal vaccine.
    Steinhoff MC; Moulton L; Clemens J
    Lancet; 1998 Jun; 351(9120):1961-2; author reply 1962. PubMed ID: 9654290
    [No Abstract]   [Full Text] [Related]  

  • 29. Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine.
    Carlson AJ; Davidson WL; McLean AA; Vella PP; Weibel RE; Woodhour AF; Hilleman MR
    Proc Soc Exp Biol Med; 1979 Sep; 161(4):558-63. PubMed ID: 39297
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pneumococcal vaccine: protection for polysaccharide germs?].
    Cerny A; Mühlemann K
    Schweiz Med Wochenschr; 1995 May; 125(19):949-51. PubMed ID: 7761804
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe local reactions to pneumococcal vaccine.
    Nelson K; Goldman JA; Perlino CA
    South Med J; 1980 Feb; 73(2):264-5. PubMed ID: 7355337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuing controversy: pneumococcal vaccine and COPD.
    Williams JH
    Chest; 1987 Aug; 92(2):193-4. PubMed ID: 3608587
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients under treatment with chronic haemodialysis: a longitudinal quasi-experimental phase IV study.
    Vandecasteele SJ; De Bacquer D; Caluwe R; Ombelet S; Van Vlem B
    Clin Microbiol Infect; 2018 Jan; 24(1):65-71. PubMed ID: 28559003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of vaccines for respiratory infections. Strategies for influenza and pneumococcal vaccines.
    Mäkelä PH; Jokinen C; Pyhälä R; Mäkelä M; Ruutu P
    Scand J Infect Dis Suppl; 1990; 70():141-8. PubMed ID: 2287896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine.
    Linnemann CC; First MR; Schiffman G
    Arch Intern Med; 1986 Aug; 146(8):1554-6. PubMed ID: 3524494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal vaccine and patients with chronic lung disease.
    Williams JH; Moser KM
    Ann Intern Med; 1986 Jan; 104(1):106-9. PubMed ID: 3940477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
    Ohshima N; Nagai H; Matsui H; Akashi S; Makino T; Akeda Y; Oishi K
    Vaccine; 2014 Feb; 32(10):1181-6. PubMed ID: 24120483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with pneumococcal vaccination among an urban elderly population in China.
    Liu S; Xu E; Liu Y; Xu Y; Wang J; Du J; Zhang X; Che X; Gu W
    Hum Vaccin Immunother; 2014; 10(10):2994-9. PubMed ID: 25483646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
    Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
    Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response.
    Rodriguez-Barradas MC; Groover JE; Lacke CE; Gump DW; Lahart CJ; Pandey JP; Musher DM
    J Infect Dis; 1996 Jun; 173(6):1347-53. PubMed ID: 8648206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.